Nutrients and Dietary Patterns Related to Osteoporosis

Osteoporosis is a common chronic disease characterized by a decrease in bone mineral density, impaired bone strength, and an increased risk of fragility fractures. Fragility fractures are associated with significant morbidity, mortality and disability and are a major public health problem worldwide. The influence of nutritional factors on the development and progression of this disease can be significant and is not yet well established. Calcium intake and vitamin D status are considered to be essential for bone metabolism homeostasis. However, some recent studies have questioned the usefulness of calcium and vitamin D supplements in decreasing the risk of fractures. The adequate intake of protein, vegetables and other nutrients is also of interest, and recommendations have been established by expert consensus and clinical practice guidelines. It is important to understand the influence of nutrients not only in isolation but also in the context of a dietary pattern, which is a complex mixture of nutrients. In this review, we evaluate the available scientific evidence for the effects of the main dietary patterns on bone health. Although some dietary patterns seem to have beneficial effects, more studies are needed to fully elucidate the true influence of diet on bone fragility.Instituto de Salud Carlos III PI18/01235European Union (EU

Barrero Rodríguez, Enrique: Derecho rendido y sociedad durmiente (Un ensayo desde el desencanto), Prólogo de Rafael Rodríguez Prieto, Editorial Betania, Madrid, 2020

--

Foeniculum sanguineum Triano y A. Pujadas (Apiaceae) nueva especie del suroeste de la Región Mediterránea

Foeniculum sanguineum Triano & A. Pujadas, sp. nov., from the south western Mediterranean Region (Spain & Morocco) is described. Its characterization and a comparative study with the related species Foeniculum vulgare Mill., has been carried out through morphological, cytological, chemical and molecular analysis. F. sanguineum is distinguished primarily for its red petals, pink pollen in fresh, and red stylopod. It is a diploid species (2n= 22). A high proportion of limonene and piperitenone oxide (absent in F. vulgare) has been found in the essential oil composition of the dry fruits of F. sanguineum and a high amount (about 50 %) of α-phellandrene in its roots and stems. Phylogenetic analyses were performed using the internal transcribed spacer sequences of nuclear ribosomal DNA (ITS) and the chloroplast rbcL gene sequences. ITS analysis supports the existence of the new species, while revealing sequence divergence both at the intraspecific and at the interspecific levels. A Single-nucleotide-polymorphism (SNP) sequence divergence found in the slow evolving chloroplast gene provided additional support for the novel species characterization, for which the name Foeniculum sanguineum is proposed

An open source framework based on Kafka-ML for Distributed DNN inference over the Cloud-to-Things continuum

The current dependency of Artificial Intelligence (AI) systems on Cloud computing implies higher transmission latency and bandwidth consumption. Moreover, it challenges the real-time monitoring of physical objects, e.g., the Internet of Things (IoT). Edge systems bring computing closer to end devices and support time-sensitive applications. However, Edge systems struggle with state-of-the-art Deep Neural Networks (DNN) due to computational resource limitations. This paper proposes a technology framework that combines the Edge-Cloud architecture concept with BranchyNet advantages to support fault-tolerant and low-latency AI predictions. The implementation and evaluation of this framework allow assessing the benefits of running Distributed DNN (DDNN) in the Cloud-to-Things continuum. Compared to a Cloud-only deployment, the results obtained show an improvement of 45.34% in the response time. Furthermore, this proposal presents an extension for Kafka-ML that reduces rigidness over the Cloud-to-Things continuum managing and deploying DDNN

Obesity and Bone Health: A Complex Relationship

Recent scientific evidence has shown an increased risk of fractures in patients with obesity, especially in those with a higher visceral adipose tissue content. This contradicts the old paradigm that obese patients were more protected than those with normal weight. Specifically, in older subjects in whom there is a redistribution of fat from subcutaneous adipose tissue to visceral adipose tissue and an infiltration of other tissues such as muscle with the consequent sarcopenia, obesity can accentuate the changes characteristic of this age group that predisposes to a greater risk of falls and fractures. Other factors that determine a greater risk in older subjects with obesity are chronic proinflammatory status, altered adipokine secretion, vitamin D deficiency, insulin resistance and reduced mobility. On the other hand, diagnostic tests may be influenced by obesity and its comorbidities as well as by body composition, and risk scales may underestimate the risk of fractures in these patients. Weight loss with physical activity programs and cessation of high-fat diets may reduce the risk. Finally, more research is needed on the efficacy of anti-osteoporotic treatments in obese patients.Instituto de Salud Carlos IIIEuropean Commission CD20/00022 PI18-00803 PI21-01069 PI18-01235European CommissionJunta de Andalucia PI-0268-201

Revisión de la evidencia científica sobre uso clínico del Trabecular Bone Score (TBS). Posiciones oficiales de la SEIOMM (2018)

La incorporación de nuevas aplicaciones tecnológicas en el campo médico conlleva un prolongado periodo de valoración de la evidencia científica que se va generando en el proceso de validación clínica. En los últimos 5 años se han generado múltiples publicaciones, comunicaciones en congresos y reuniones de sociedades científicas. La aplicación del Trabecular Bone Score (TBS) ha recibido también la atención de la Sociedad Internacional de Densitometría Clínica (The International Society for Clinical Densitometry -ISCD-) que la ha incorporado a sus posiciones oficiales

Mechanisms Involved in the Relationship between Vitamin D and Insulin Resistance: Impact on Clinical Practice

This research was funded by the Institute of Health Carlos III grants (PI18-00803 and PI18-01235), co-funded by the European Regional Development Fund (FEDER) and Junta de Andalucia (PI-0268-2019). In addition, V.C.-B. and C.G.-F. are funded by postdoctoral fellowships from the Junta de Andalucia and Institute of Health Carlos III respectively (RH-0141-2020; CD20/00022).Recent evidence has revealed anti-inflammatory properties of vitamin D as well as extraskeletal activity. In this context, vitamin D seems to be involved in infections, autoimmune diseases, cardiometabolic diseases, and cancer development. In recent years, the relationship between vitamin D and insulin resistance has been a topic of growing interest. Low 25-hydroxyvitamin D (25(OH)D) levels appear to be associated with most of the insulin resistance disorders described to date. In fact, vitamin D deficiency may be one of the factors accelerating the development of insulin resistance. Vitamin D deficiency is a common problem in the population and may be associated with the pathogenesis of diseases related to insulin resistance, such as obesity, diabetes, metabolic syndrome (MS) and polycystic ovary syndrome (PCOS). An important question is the identification of 25(OH)D levels capable of generating an effect on insulin resistance, glucose metabolism and to decrease the risk of developing insulin resistance related disorders. The benefits of 25(OH)D supplementation/repletion on bone health are well known, and although there is a biological plausibility linking the status of vitamin D and insulin resistance supported by basic and clinical research findings, well-designed randomized clinical trials as well as basic research are necessary to know the molecular pathways involved in this association.Institute of Health Carlos III grants PI18-00803 PI18-01235European Commission Junta de Andalucia PI-0268-2019Instituto de Salud Carlos III RH-0141-2020 CD20/0002